Current Research Studies

COVID-19 – Vaccine Clinical Trials in Children

Condition or Therapy:



Infectious Diseases

What is the goal of this study?

The goal of this phase 2/phase 3 study is to evaluate the safety, tolerability and immunogenicity of an RNA vaccine candidate against COVID-19 in healthy children.

Who can join the study?

This study might be a good fit for children who:

  • Are ages 6 months to 11 years old

 See the study flyer.

What will happen if my child takes part in this study?

If you decide to participate in this research study, your child would:

  • Receive two doses of a COVID-19 vaccine during the study.
  • Receive two to four shots during the study, as some children may get placebo first and vaccine later.
  • Have blood drawn to measure antibodies (“germ fighters”).
  • Record reactions after the shots and tell the study team.
  • Receive $100 for each planned clinic visit.
  • Receive $5 for each full week of completed e-diary.

Who can I contact for more information?

To learn more, email the study team.

Study Location(s):

Seattle Children's Hospital campus

Principal Investigator:

Dr. Janet Englund
Center: Center for Clinical and Translational Research